Home > Healthcare > Pharmaceuticals > Finished Drug Form > U.S. Medical Marijuana Market

U.S. Medical Marijuana Market Share

  • Report ID: GMI2890
  • Published Date: Oct 2022
  • Report Format: PDF

U.S. Medical Marijuana Market Share

Some of the leading companies in the U.S. medical marijuana market are:

  • Aurora Cannabis Inc
  • GW Pharmaceuticals
  • Cannabis Sativa Inc
  • Emerald Health Therapeutics Inc
  • The Cronos Group Inc
  • Tilray
  • Lexaria Bioscience Corp
  • Curaleaf
  • Green Roads
  • Canopy Growth Corporation
  • Gaia Herbs
  • Medical Marijuana
  • Folium Biosciences.

These companies are focusing on product commercialization and patents by means of collaboration with related firms.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. market for medical marijuana was valued at over USD 9 billion in 2021 and is projected to expand at more than 10% CAGR between the estimated timeframe of 2022-2030.

Pain management applications was over USD 7 billion in 2021 due to the rise in the number of patients with chronic and neuropathic pain in the U.S.

South Atlantic U.S. medical marijuana market size is anticipated to exceed USD 3 billion by 2030 owing to increasing efforts to boost the production of cannabis products.

Tilray, Curaleaf, Green Roads, CHARLOTTE’S WEB, Gaia Herbs, Medical Marijuana, and Folium Biosciences are some of the leading companies in the U.S. market.

U.S. Medical Marijuana Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 16
  • Tables & Figures: 413
  • Countries covered: 36
  • Pages: 225
 Download Free Sample